Reports Q4 revenue $2.62B, consensus $2.58B. “In the fourth quarter, we delivered impressive revenue growth of nearly 15%, including approximately 5% organic growth, while also improving our profitability,” said Jim Davis, Chairman, CEO, and President. “For the full year, we drove revenue growth of close to 7%, including approximately 3% from organic growth. Our team completed eight acquisitions, including LifeLabs in Canada, expanded our advanced diagnostics portfolio, and extended our geographic and market reach with new clinical, consumer and health plan customers.”
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DGX:
- Notable companies reporting before tomorrow’s open
- Quest Diagnostics (DGX) Q4 Earnings Cheat Sheet
- Quest Diagnostics names Adrienne Brott Chief Quality, Regulatory Affairs Officer
- Quest Diagnostics upgraded to Outperform from Market Perform at Leerink
- Quest Diagnostics price target raised to $177 from $174 at Mizuho